Chapter/Section Purchase

1 Subcutaneous Medicine Delivery Devices Market Overview
1.1 Product Overview and Scope of Subcutaneous Medicine Delivery Devices
1.2 Subcutaneous Medicine Delivery Devices Segment by Type
1.2.1 Global Subcutaneous Medicine Delivery Devices Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Implantable Subcutaneous Medicine Delivery Device
1.2.3 Injection Type Subcutaneous Medicine Delivery Device
1.3 Subcutaneous Medicine Delivery Devices Segment by Application
1.3.1 Global Subcutaneous Medicine Delivery Devices Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Subcutaneous Medicine Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Subcutaneous Medicine Delivery Devices Revenue 2017-2028
1.4.2 Global Subcutaneous Medicine Delivery Devices Sales 2017-2028
1.4.3 Subcutaneous Medicine Delivery Devices Market Size by Region: 2017 Versus 2021 Versus 2028
2 Subcutaneous Medicine Delivery Devices Market Competition by Manufacturers
2.1 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Manufacturers (2017-2022)
2.2 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Subcutaneous Medicine Delivery Devices Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Subcutaneous Medicine Delivery Devices Manufacturing Sites, Area Served, Product Type
2.5 Subcutaneous Medicine Delivery Devices Market Competitive Situation and Trends
2.5.1 Subcutaneous Medicine Delivery Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Subcutaneous Medicine Delivery Devices Players Market Share by Revenue
2.5.3 Global Subcutaneous Medicine Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Subcutaneous Medicine Delivery Devices Retrospective Market Scenario by Region
3.1 Global Subcutaneous Medicine Delivery Devices Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Subcutaneous Medicine Delivery Devices Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
3.3.1 North America Subcutaneous Medicine Delivery Devices Sales by Country
3.3.2 North America Subcutaneous Medicine Delivery Devices Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
3.4.1 Europe Subcutaneous Medicine Delivery Devices Sales by Country
3.4.2 Europe Subcutaneous Medicine Delivery Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Subcutaneous Medicine Delivery Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Subcutaneous Medicine Delivery Devices Sales by Region
3.5.2 Asia Pacific Subcutaneous Medicine Delivery Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
3.6.1 Latin America Subcutaneous Medicine Delivery Devices Sales by Country
3.6.2 Latin America Subcutaneous Medicine Delivery Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Subcutaneous Medicine Delivery Devices Sales by Country
3.7.2 Middle East and Africa Subcutaneous Medicine Delivery Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Subcutaneous Medicine Delivery Devices Historic Market Analysis by Type
4.1 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2017-2022)
4.2 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Type (2017-2022)
4.3 Global Subcutaneous Medicine Delivery Devices Price by Type (2017-2022)
5 Global Subcutaneous Medicine Delivery Devices Historic Market Analysis by Application
5.1 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2017-2022)
5.2 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Application (2017-2022)
5.3 Global Subcutaneous Medicine Delivery Devices Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Eli Lily
6.2.1 Eli Lily Corporation Information
6.2.2 Eli Lily Description and Business Overview
6.2.3 Eli Lily Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Eli Lily Subcutaneous Medicine Delivery Devices Product Portfolio
6.2.5 Eli Lily Recent Developments/Updates
6.3 Galaxo
6.3.1 Galaxo Corporation Information
6.3.2 Galaxo Description and Business Overview
6.3.3 Galaxo Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Galaxo Subcutaneous Medicine Delivery Devices Product Portfolio
6.3.5 Galaxo Recent Developments/Updates
6.4 HMD pharmaceuticals
6.4.1 HMD pharmaceuticals Corporation Information
6.4.2 HMD pharmaceuticals Description and Business Overview
6.4.3 HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Product Portfolio
6.4.5 HMD pharmaceuticals Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Merck Subcutaneous Medicine Delivery Devices Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Novartis Subcutaneous Medicine Delivery Devices Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novo Nordisk Subcutaneous Medicine Delivery Devices Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Pfizer Subcutaneous Medicine Delivery Devices Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Sanofi Subcutaneous Medicine Delivery Devices Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Teva Pharmaceutical
6.10.1 Teva Pharmaceutical Corporation Information
6.10.2 Teva Pharmaceutical Description and Business Overview
6.10.3 Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Product Portfolio
6.10.5 Teva Pharmaceutical Recent Developments/Updates
6.11 Zogenix
6.11.1 Zogenix Corporation Information
6.11.2 Zogenix Subcutaneous Medicine Delivery Devices Description and Business Overview
6.11.3 Zogenix Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Zogenix Subcutaneous Medicine Delivery Devices Product Portfolio
6.11.5 Zogenix Recent Developments/Updates
6.12 BD
6.12.1 BD Corporation Information
6.12.2 BD Subcutaneous Medicine Delivery Devices Description and Business Overview
6.12.3 BD Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.12.4 BD Subcutaneous Medicine Delivery Devices Product Portfolio
6.12.5 BD Recent Developments/Updates
6.13 Insulet Corporation
6.13.1 Insulet Corporation Corporation Information
6.13.2 Insulet Corporation Subcutaneous Medicine Delivery Devices Description and Business Overview
6.13.3 Insulet Corporation Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Insulet Corporation Subcutaneous Medicine Delivery Devices Product Portfolio
6.13.5 Insulet Corporation Recent Developments/Updates
6.14 Enable Injections
6.14.1 Enable Injections Corporation Information
6.14.2 Enable Injections Subcutaneous Medicine Delivery Devices Description and Business Overview
6.14.3 Enable Injections Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Enable Injections Subcutaneous Medicine Delivery Devices Product Portfolio
6.14.5 Enable Injections Recent Developments/Updates
6.15 West Pharmaceutical Services
6.15.1 West Pharmaceutical Services Corporation Information
6.15.2 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Description and Business Overview
6.15.3 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.15.4 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Product Portfolio
6.15.5 West Pharmaceutical Services Recent Developments/Updates
6.16 Ypsomed AG
6.16.1 Ypsomed AG Corporation Information
6.16.2 Ypsomed AG Subcutaneous Medicine Delivery Devices Description and Business Overview
6.16.3 Ypsomed AG Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Ypsomed AG Subcutaneous Medicine Delivery Devices Product Portfolio
6.16.5 Ypsomed AG Recent Developments/Updates
6.17 Elcam Medical
6.17.1 Elcam Medical Corporation Information
6.17.2 Elcam Medical Subcutaneous Medicine Delivery Devices Description and Business Overview
6.17.3 Elcam Medical Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Elcam Medical Subcutaneous Medicine Delivery Devices Product Portfolio
6.17.5 Elcam Medical Recent Developments/Updates
6.18 Amgen
6.18.1 Amgen Corporation Information
6.18.2 Amgen Subcutaneous Medicine Delivery Devices Description and Business Overview
6.18.3 Amgen Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Amgen Subcutaneous Medicine Delivery Devices Product Portfolio
6.18.5 Amgen Recent Developments/Updates
6.19 Wilhelm Haselmeier
6.19.1 Wilhelm Haselmeier Corporation Information
6.19.2 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Description and Business Overview
6.19.3 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Product Portfolio
6.19.5 Wilhelm Haselmeier Recent Developments/Updates
7 Subcutaneous Medicine Delivery Devices Manufacturing Cost Analysis
7.1 Subcutaneous Medicine Delivery Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Subcutaneous Medicine Delivery Devices
7.4 Subcutaneous Medicine Delivery Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Subcutaneous Medicine Delivery Devices Distributors List
8.3 Subcutaneous Medicine Delivery Devices Customers
9 Subcutaneous Medicine Delivery Devices Market Dynamics
9.1 Subcutaneous Medicine Delivery Devices Industry Trends
9.2 Subcutaneous Medicine Delivery Devices Market Drivers
9.3 Subcutaneous Medicine Delivery Devices Market Challenges
9.4 Subcutaneous Medicine Delivery Devices Market Restraints
10 Global Market Forecast
10.1 Subcutaneous Medicine Delivery Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Subcutaneous Medicine Delivery Devices by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Subcutaneous Medicine Delivery Devices by Type (2023-2028)
10.2 Subcutaneous Medicine Delivery Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Subcutaneous Medicine Delivery Devices by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Subcutaneous Medicine Delivery Devices by Application (2023-2028)
10.3 Subcutaneous Medicine Delivery Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Subcutaneous Medicine Delivery Devices by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Subcutaneous Medicine Delivery Devices by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer